We are developing a comprehensive ischemic heart disease model for testing preventive, diagnostic and therapeutic technologies. The modeling platform is generic and can support the testing of various drugs, medical devices, biomarkers, and risk factors. The model utilizes state-of-the-art knowledge and validated evidence in conceptualization and development. 

The model can serve to test the comparative effectiveness as well as health economic questions, and it is available, on a limited basis, for external use by subscription. Sponsorship can secure full or limited platform use or generation of the results for different purposes, including reimbursement submissions.